Camp4 Therapeutics Corp 10-Q filing
Filed 2025-11-06 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001736730-25-000094
- Form type
- 10-Q
- CIK
- 0001736730
- Primary document
- https://www.sec.gov/Archives/edgar/data/1736730/000173673025000094/camp-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Camp4 Therapeutics Corp.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $3.1M | - | - |
| Operating Income | $-39.8M | - | - |
| Net Income | $-40.1M | - | - |
| Eps Basic | -1.78 | - | - |
| Eps Diluted | -1.78 | - | - |
| Cash And Equivalents | $75.3M | - | - |
| Total Assets | $86.4M | - | - |
| Total Liabilities | $27.7M | - | - |
| Shareholders Equity | $58.7M | - | - |
| Operating Cash Flow | $-35.8M | - | - |
| Capital Expenditures | $279,000 | - | - |